NewsRx

Search our medical news database

Adverse Drug Effects

Study Finds Third Generation Oral Contraceptive Increases Risk Of Blood Clots

Published in Women's Health Weekly, August 30th, 2001

Women taking third generation oral contraceptives have a 1.7-fold increased risk of venous clotting (thrombosis) compared with those taking second generation oral contraceptives, according to a recent study.

Although the risks are small, they should be considered when deciding which contraceptive pill to use, report the authors.

Researchers at the University Medical Centre Utrecht in The Netherlands pooled the results of studies assessing risk of venous clotting among women using oral contraceptives before October 1995. The team chose October 1995 as the end date because at that time four studies were published highlighting the possible risk of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook